EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.2276
March 31, 2026 -0.3057
December 31, 2025 -0.2279
September 30, 2025 -0.226
June 30, 2025 -0.1497
March 31, 2025 -0.1863
December 31, 2024 -0.1692
September 30, 2024 -0.2328
June 30, 2024 -0.1995
March 31, 2024 -0.1473
December 31, 2023 -0.2167
September 30, 2023 -0.1086
June 30, 2023 -0.1486
March 31, 2023 -0.2102
December 31, 2022 -0.3188
Date Value
September 30, 2022 -0.0085
June 30, 2022 0.006
March 31, 2022 -0.1108
December 31, 2021 -0.0786
September 30, 2021 -0.0353
June 30, 2021 -0.053
March 31, 2021 -0.0164
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Atai Beckley, Inc. -0.0902
Avadel Pharmaceuticals Plc 0.0002
Jazz Pharmaceuticals Plc 2.778
Eli Lilly & Co. 7.939
Perrigo Co. Plc 0.5337

EPS Diluted (Quarterly) Related Metrics